Belvedere Trading LLC Relmada Therapeutics, Inc. Put Options Transaction History

Belvedere Trading LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Nov 01, 2024	BUY	$2.93 - $4.94 $42,778 - $72,124	14,600 New	14,600 $43,000
Q1 2024 May 09, 2024	BUY	$3.1 - $6.8 $43,400 - $95,200	14,000 Added 2333.33%	14,600 $67,000
Q4 2023 Feb 13, 2024	BUY	$2.45 - $4.22 $1,470 - $2,532	600 New	600 $2,000
Q2 2022 Jul 21, 2022	SELL	$16.5 - $30.34 $282,150 - $518,814	-17,100 Reduced 55.34%	13,800 $321,000
Q1 2022 Apr 20, 2022	BUY	$16.72 - $26.99 $516,647 - $833,991	30,900 New	30,900 $811,000

11.5M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $10.3M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.